> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Joint Panel to Review Pediatric-use Opioids
- URL: https://www.fdaweb.com/joint-panel-to-review-pediatric-use-opioids/
- Published: 2019-08-21T12:00:00.000Z
- Updated: 2026-09-15T01:45:18.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144818

*Federal Register* notice: FDA has announced a 9/26 joint Pediatric Advisory Committee and Drug Safety and Risk Management Advisory Committee meeting. Panel members are scheduled to discuss the pediatric-focused safety review for OxyContin (oxycodone hydrochloride) extended-release tablets. They will also discuss pediatric data considerations for opioid analgesics labeling and Pediatric Research Equity Act studies for opioids generally, using Opana IR as an example. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-08-21/pdf/2019-17997.pdf?ref=fdaweb.com).